Return on investment in needle and syringe programs in Australia: report

Appendix E Detailed tables on quality of life effects of NSPs

Page last updated: 2002

This Table is separated into six smaller tables in this HTML version for accessibility reasons. It is presented as one table in the PDF version.

HIV - Survivors and life years gained
HIV - Quality adjusted life years and QALYs gained
HCV - Survivors and life years gained
HCV - Quality adjusted life years and QALYs gained
All life years and QALYs gained
HIV, HCV and HIV+HCV projections

HIV - Survivors and life years gained

YearSurvivors without HIVSurvivors with HIV
CD4 >500 Diagnosed
Survivors with HIV
CD4 >500
Undiagnosed
Survivors with HIV
CD4 <500
Diagnosed
Survivors with HIV
CD4 <500
Undiagnosed
Survivors with HIV
AIDS
Diagnosed
Survivors with HIV
Total
Life Years Gained
1991
786
544
136
47
5
10
742
44
1992
1,309
887
222
107
12
23
1,251
58
1993
2,070
1,369
342
210
23
44
1,988
82
1994
3,153
2,033
508
373
41
78
3,033
120
1995
4,684
2,950
738
616
68
131
4,503
181
1996
6,828
4,213
1,053
1,004
112
192
6,574
254
1997
9,797
5,935
1,484
1,573
175
278
9,445
352
1998
13,853
8,255
2,064
2,399
267
393
13,378
475
1999
19,304
11,320
2,830
3,585
398
540
18,673
631
2000
26,488
15,277
3,819
5,266
585
725
25,672
816
2001
26,190
12,681
3,170
7,551
839
946
25,187
1,003
2002
25,898
9,833
2,458
10,027
1,114
1,219
24,651
1,247
2003
25,608
7,142
1,785
12,247
1,361
1,521
24,056
1,552
2004
25,317
4,896
1,224
13,901
1,545
1,834
23,400
1,917
2005
25,035
3,230
807
14,865
1,652
2,130
22,684
2,351
2006
24,756
2,105
526
15,196
1,688
2,392
21,907
2,849
2007
24,477
1,363
341
15,094
1,677
2,602
21,077
3,400
2008
24,208
876
219
14,733
1,637
2,746
20,211
3,997
2009
23,944
560
140
14,210
1,579
2,828
19,317
4,627
2010
23,691
356
89
13,603
1,511
2,849
18,408
5,283
2011
23,455
225
56
12,958
1,440
2,824
17,503
5,952
2012
23,234
141
35
12,296
1,366
2,762
16,600
6,634
2013
23,037
88
22
11,638
1,293
2,674
15,715
7,322
2014
22,874
55
14
10,996
1,222
2,569
14,856
8,018
2015
22,755
34
9
10,375
1,153
2,453
14,024
8,731
2016
22,693
21
5
9,781
1,087
2,331
13,225
9,468
2017
22,625
13
3
9,214
1,024
2,208
12,462
10,163
2018
22,553
8
2
8,677
964
2,086
11,737
10,816
2019
22,470
5
1
8,165
907
1,968
11,046
11,424
2020
22,380
3
1
7,679
853
1,855
10,391
11,989
2021
22,279
2
0
7,219
802
1,747
9,770
12,509
2022
22,170
1
0
6,784
754
1,644
9,183
12,987
2023
22,050
1
0
6,371
708
1,546
8,626
13,424
2024
21,917
0
0
5,980
664
1,453
8,097
13,820
2025
21,772
0
0
5,610
623
1,365
7,598
14,174
2026
21,610
0
0
5,258
584
1,281
7,123
14,487
2027
21,432
0
0
4,925
547
1,202
6,674
14,758
2028
21,234
0
0
4,608
512
1,127
6,247
14,987
2029
21,015
0
0
4,307
479
1,056
5,842
15,173
2030
20,773
0
0
4,021
447
988
5,456
15,317
2031
20,510
0
0
3,750
417
924
5,091
15,419
2032
20,223
0
0
3,492
388
864
4,744
15,479
2033
19,911
0
0
3,248
361
806
4,415
15,496
2034
19,571
0
0
3,016
335
751
4,102
15,469
2035
19,204
0
0
2,796
311
699
3,806
15,398
2036
18,805
0
0
2,587
287
650
3,524
15,281
2037
18,371
0
0
2,388
265
603
3,256
15,115
2038
17,904
0
0
2,199
244
558
3,001
14,903
2039
17,409
0
0
2,021
225
516
2,762
14,647
2040
16,874
0
0
1,851
206
476
2,533
14,341
2041
16,302
0
0
1,690
188
438
2,316
13,986
2042
15,697
0
0
1,539
171
402
2,112
13,585
2043
15,053
0
0
1,395
155
368
1,918
13,135
2044
14,376
0
0
1,260
140
336
1,736
12,640
2045
13,662
0
0
1,132
126
305
1,563
12,099
2046
12,916
0
0
1,013
113
276
1,402
11,514
2047
12,144
0
0
901
100
249
1,250
10,894
2048
11,347
0
0
796
88
224
1,108
10,239
2049
10,526
0
0
699
78
200
977
9,549
2050
9,689
0
0
609
68
178
855
8,834
2051
8,845
0
0
526
58
157
741
8,104
2052
8,001
0
0
451
50
137
638
7,363
2053
7,164
0
0
382
42
119
543
6,621
2054
6,344
0
0
320
36
103
459
5,885
2055
5,553
0
0
265
29
88
382
5,171
2056
4,800
0
0
217
24
75
316
4,484
2057
4,090
0
0
175
19
63
257
3,833
2058
3,433
0
0
139
15
52
206
3,227
2059
2,838
0
0
109
12
42
163
2,675
2060
2,305
0
0
84
9
34
127
2,178
2061
1,842
0
0
63
7
27
97
1,745
2062
1,450
0
0
47
5
21
73
1,377
2063
1,120
0
0
35
4
16
55
1,065
2064
853
0
0
25
3
12
40
813
2065
635
0
0
18
2
8
28
607
2066
454
0
0
12
1
6
19
435
2067
308
0
0
8
1
4
13
295
2068
188
0
0
5
1
2
8
180
2069
90
0
0
2
0
1
3
87
2070
0
0
0
0
0
0
0
0
Total
1,162,533
96,422
24,103
344,734
38,302
71,410
574,971
587,562
Top of page

HIV - Quality adjusted life years and QALYs gained

YearCD4 >500
Diagnosed
CD4 >500
Undiagnosed
CD4 <500
Diagnosed
CD4 <500
Undiagnosed
AIDS
Diagnosed
TotalHIV QALYs gained
1991
473
128
36
5
6
648
138
1992
772
209
81
11
14
1,087
222
1993
1,191
321
160
21
27
1,720
350
1994
1,769
478
283
37
48
2,615
538
1995
2,567
694
468
61
81
3,871
814
1996
3,665
990
763
101
119
5,638
1,190
1997
5,163
1,395
1,195
158
172
8,084
1,713
1998
7,182
1,940
1,823
240
244
11,429
2,424
1999
9,848
2,660
2,725
358
335
15,926
3,378
2000
13,291
3,590
4,002
527
450
21,859
4,629
2001
11,032
2,980
5,739
755
587
21,093
5,097
2002
8,555
2,311
7,621
1,003
756
20,244
5,654
2003
6,214
1,678
9,308
1,225
943
19,367
6,241
2004
4,260
1,151
10,565
1,391
1,137
18,502
6,815
2005
2,810
759
11,297
1,487
1,321
17,673
7,362
2006
1,831
494
11,549
1,519
1,483
16,877
7,879
2007
1,186
321
11,471
1,509
1,613
16,100
8,376
2008
762
206
11,197
1,473
1,703
15,341
8,867
2009
487
132
10,800
1,421
1,753
14,593
9,351
2010
310
84
10,338
1,360
1,766
13,858
9,833
2011
196
53
9,848
1,296
1,751
13,143
10,312
2012
123
33
9,345
1,229
1,712
12,442
10,792
2013
77
21
8,845
1,164
1,658
11,764
11,273
2014
48
13
8,357
1,100
1,593
11,111
11,763
2015
30
8
7,885
1,038
1,521
10,482
12,274
2016
18
5
7,434
978
1,445
9,880
12,813
2017
11
3
7,003
922
1,369
9,307
13,318
2018
7
2
6,595
868
1,293
8,764
13,789
2019
4
1
6,205
816
1,220
8,247
14,223
2020
3
1
5,836
768
1,150
7,757
14,623
2021
2
0
5,486
722
1,083
7,293
14,986
2022
1
0
5,156
679
1,019
6,855
15,316
2023
1
0
4,842
637
959
6,439
15,612
2024
0
0
4,545
598
901
6,043
15,874
2025
0
0
4,264
561
846
5,671
16,101
2026
0
0
3,996
526
794
5,316
16,294
2027
0
0
3,743
492
745
4,981
16,451
2028
0
0
3,502
461
699
4,662
16,572
2029
0
0
3,273
431
655
4,359
16,656
2030
0
0
3,056
402
613
4,071
16,703
2031
0
0
2,850
375
573
3,798
16,712
2032
0
0
2,654
349
536
3,539
16,685
2033
0
0
2,468
325
500
3,293
16,618
2034
0
0
2,292
302
466
3,059
16,512
2035
0
0
2,125
280
433
2,838
16,366
2036
0
0
1,966
258
403
2,627
16,177
2037
0
0
1,815
239
374
2,427
15,943
2038
0
0
1,671
220
346
2,237
15,667
2039
0
0
1,536
203
320
2,058
15,350
2040
0
0
1,407
185
295
1,887
14,986
2041
0
0
1,284
169
272
1,725
14,577
2042
0
0
1,170
154
249
1,573
14,124
2043
0
0
1,060
140
228
1,428
13,626
2044
0
0
958
126
208
1,292
13,084
2045
0
0
860
113
189
1,163
12,499
2046
0
0
770
102
171
1,043
11,873
2047
0
0
685
90
154
929
11,215
2048
0
0
605
79
139
823
10,524
2049
0
0
531
70
124
725
9,801
2050
0
0
463
61
110
634
9,054
2051
0
0
400
52
97
549
8,295
2052
0
0
343
45
85
473
7,528
2053
0
0
290
38
74
402
6,762
2054
0
0
243
32
64
339
6,005
2055
0
0
201
26
55
282
5,271
2056
0
0
165
22
47
233
4,567
2057
0
0
133
17
39
189
3,901
2058
0
0
106
14
32
151
3,282
2059
0
0
83
11
26
120
2,718
2060
0
0
64
8
21
93
2,212
2061
0
0
48
6
17
71
1,771
2062
0
0
36
5
13
53
1,397
2063
0
0
27
4
10
40
1,080
2064
0
0
19
3
7
29
824
2065
0
0
14
2
5
20
615
2066
0
0
9
1
4
14
440
2067
0
0
6
1
2
9
298
2068
0
0
4
1
1
6
182
2069
0
0
2
0
1
2
87
2070
0
0
0
0
0
0
0
Total
83,887
22,657
261,998
34,472
44,274
447,288
715,245
Top of page

HCV - Survivors and life years gained

YearSurvivors without HCVSurvivors with HCV
Not Chronic
Survivors with HCV
Stage 0/1
Diagnosed
Survivors with HCV
Stage 0/1
Undiagnosed
Survivors with HCV
Stage 2/3
Diagnosed
Survivors with HCV
Stage 2/3
Undiagnosed
Survivors with HCV
Cirrhosis
Diagnosed
Survivors with HCV
Cirrhosis
Undiagnosed
Survivors with HCV
HCC
Diagnosed
Survivors with HCV
Liver Failure Diagnosed
Survivors with HCV
Total
Life Years Gained
1991
5,204
1,300
2,233
1,489
132
44
3
1
0
0
5,202
2
1992
6,637
1,658
2,822
1,881
200
67
6
2
0
0
6,636
1
1993
8,114
2,028
3,419
2,279
279
93
11
3
0
1
8,112
2
1994
9,650
2,412
4,031
2,687
372
124
18
4
0
1
9,648
2
1995
11,256
2,814
4,663
3,108
477
159
26
7
0
1
11,254
2
1996
12,949
3,236
5,321
3,547
595
198
37
9
0
2
12,943
6
1997
14,738
3,683
6,011
4,007
727
242
51
13
1
2
14,734
4
1998
16,639
4,158
6,737
4,491
872
291
68
17
1
3
16,634
5
1999
18,663
4,665
7,505
5,004
1,031
344
88
22
1
4
18,659
4
2000
20,826
5,205
8,321
5,547
1,205
402
112
28
1
5
20,820
6
2001
20,597
5,148
8,068
5,379
1,367
456
139
35
2
6
20,592
5
2002
20,370
5,091
7,823
5,216
1,516
505
170
43
2
8
20,364
6
2003
20,145
5,035
7,586
5,058
1,654
551
204
51
3
9
20,139
6
2004
19,930
4,981
7,359
4,906
1,782
594
241
60
3
11
19,923
7
2005
19,727
4,930
7,143
4,762
1,901
634
281
70
3
12
19,721
6
2006
19,538
4,883
6,937
4,625
2,012
671
324
81
4
14
19,533
5
2007
19,363
4,840
6,741
4,494
2,116
705
369
92
5
16
19,357
6
2008
19,202
4,799
6,556
4,370
2,213
738
416
104
5
18
19,196
6
2009
19,053
4,762
6,379
4,253
2,304
768
465
116
6
20
19,047
6
2010
18,919
4,728
6,212
4,142
2,389
796
517
129
6
22
18,913
6
2011
18,799
4,699
6,054
4,036
2,469
823
570
143
7
24
18,794
5
2012
18,693
4,672
5,905
3,937
2,544
848
625
156
8
27
18,687
6
2013
18,603
4,650
5,765
3,843
2,616
872
682
170
8
29
18,598
5
2014
18,528
4,631
5,634
3,756
2,683
894
740
185
9
31
18,523
5
2015
18,469
4,617
5,511
3,674
2,748
916
800
200
10
34
18,466
3
2016
18,428
4,606
5,397
3,598
2,810
937
862
215
11
36
18,425
3
2017
18,384
4,595
5,284
3,523
2,867
956
924
231
11
39
18,380
4
2018
18,334
4,582
5,173
3,449
2,919
973
987
247
12
42
18,330
4
2019
18,281
4,569
5,063
3,375
2,966
989
1,051
263
13
44
18,276
5
2020
18,222
4,555
4,955
3,303
3,008
1,003
1,115
279
14
47
18,218
4
2021
18,158
4,538
4,847
3,232
3,046
1,015
1,179
295
14
49
18,152
6
2022
18,087
4,520
4,741
3,161
3,079
1,026
1,243
311
15
52
18,081
6
2023
18,009
4,501
4,635
3,090
3,107
1,036
1,306
327
16
55
18,002
7
2024
17,923
4,479
4,530
3,020
3,131
1,044
1,369
342
17
57
17,915
8
2025
17,828
4,455
4,425
2,950
3,149
1,050
1,432
358
18
60
17,819
9
2026
17,723
4,428
4,321
2,881
3,163
1,054
1,493
373
18
62
17,713
10
2027
17,608
4,399
4,216
2,811
3,172
1,057
1,552
388
19
65
17,595
13
2028
17,481
4,367
4,112
2,741
3,176
1,059
1,611
403
20
67
17,469
12
2029
17,342
4,332
4,007
2,671
3,175
1,058
1,667
417
20
69
17,327
15
2030
17,189
4,293
3,902
2,601
3,168
1,056
1,721
430
21
71
17,171
18
2031
17,021
4,251
3,796
2,531
3,157
1,052
1,772
443
22
74
17,002
19
2032
16,836
4,204
3,690
2,460
3,140
1,047
1,820
455
22
75
16,816
20
2033
16,634
4,153
3,582
2,388
3,117
1,039
1,865
466
23
77
16,610
24
2034
16,413
4,096
3,474
2,316
3,089
1,030
1,906
477
23
79
16,388
25
2035
16,171
4,036
3,364
2,242
3,055
1,018
1,943
486
24
80
16,144
27
2036
15,909
3,970
3,253
2,168
3,015
1,005
1,975
494
24
81
15,880
29
2037
15,624
3,898
3,140
2,093
2,969
990
2,002
500
25
82
15,592
32
2038
15,315
3,821
3,026
2,017
2,917
972
2,023
506
25
83
15,282
33
2039
14,981
3,736
2,911
1,940
2,859
953
2,038
510
25
84
14,947
34
2040
14,622
3,646
2,793
1,862
2,794
931
2,047
512
25
84
14,585
37
2041
14,235
3,549
2,674
1,783
2,723
908
2,048
512
25
84
14,197
38
2042
13,820
3,446
2,554
1,703
2,645
882
2,042
511
25
83
13,783
37
2043
13,377
3,334
2,432
1,621
2,561
854
2,029
507
25
83
13,338
39
2044
12,906
3,216
2,308
1,539
2,471
824
2,007
502
25
82
12,867
39
2045
12,405
3,092
2,183
1,456
2,375
792
1,976
494
24
80
12,368
37
2046
11,876
2,959
2,057
1,371
2,272
757
1,937
484
24
78
11,837
39
2047
11,321
2,821
1,930
1,287
2,164
721
1,889
472
23
76
11,284
37
2048
10,740
2,677
1,803
1,202
2,051
684
1,832
458
22
74
10,707
33
2049
10,135
2,526
1,675
1,117
1,933
644
1,766
441
22
71
10,102
33
2050
9,511
2,369
1,548
1,032
1,811
604
1,691
423
21
68
9,478
33
2051
8,869
2,209
1,422
948
1,686
562
1,609
402
20
64
8,838
31
2052
8,216
2,047
1,297
865
1,559
520
1,519
380
19
60
8,187
29
2053
7,556
1,883
1,176
784
1,431
477
1,423
356
17
56
7,530
26
2054
6,893
1,717
1,057
705
1,302
434
1,322
331
16
52
6,868
25
2055
6,235
1,552
942
628
1,175
392
1,217
304
15
48
6,210
25
2056
5,588
1,392
832
555
1,051
350
1,110
277
14
43
5,567
21
2057
4,960
1,235
728
486
930
310
1,001
250
12
39
4,940
20
2058
4,358
1,085
631
421
815
272
894
224
11
34
4,342
16
2059
3,787
943
541
360
706
235
789
197
10
30
3,771
16
2060
3,253
810
458
305
605
202
689
172
8
26
3,241
12
2061
2,760
687
383
255
511
170
593
148
7
22
2,747
13
2062
2,311
576
316
211
427
142
504
126
6
19
2,302
9
2063
1,899
473
256
171
349
116
420
105
5
15
1,890
9
2064
1,534
382
204
136
281
94
344
86
4
12
1,527
7
2065
1,219
304
160
107
223
74
277
69
3
10
1,214
5
2066
952
237
124
82
173
58
219
55
3
8
948
4
2067
731
182
94
62
133
44
170
43
2
6
728
3
2068
550
137
70
46
99
33
130
32
2
4
547
3
2069
405
101
51
34
73
24
97
24
1
3
404
1
2070
290
72
36
24
52
17
70
17
1
2
288
2
2071
198
49
24
16
35
12
48
12
1
1
196
2
2072
127
31
15
10
23
8
31
8
0
1
126
1
2073
73
19
9
6
13
4
18
5
0
0
74
-1
2074
32
8
4
3
6
2
8
2
0
0
33
-1
2075
0
0
0
0
0
0
0
0
0
0
0
0
Total
1,036,257
258,775
285,367
190,245
150,916
50,307
79,585
19,898
975
3,248
1,035,093
1,164
Top of page

HCV - Quality adjusted life years and QALYs gained

YearNot ChronicStage 0/1 DiagnosedStage 0/1 UndiagnosedStage 2/3 DiagnosedStage 2/3 UndiagnosedCirrhosis DiagnosedCirrhosis UndiagnosedHCC DiagnosedLiver Failure DiagnosedTotalHCV QALYs Gained
1991
1,300
1,831
1,400
108
41
2
1
0
0
4,683
520
1992
1,658
2,314
1,768
164
63
4
2
0
0
5,973
664
1993
2,028
2,804
2,142
229
87
7
3
0
0
7,300
814
1994
2,412
3,305
2,526
305
117
13
3
0
0
8,681
969
1995
2,814
3,824
2,922
391
149
19
6
0
0
10,124
1,132
1996
3,236
4,363
3,334
488
186
26
8
0
1
11,642
1,307
1997
3,683
4,929
3,767
596
227
36
11
0
1
13,249
1,489
1998
4,158
5,524
4,222
715
274
47
14
0
1
14,955
1,683
1999
4,665
6,154
4,704
845
323
61
18
0
1
16,773
1,891
2000
5,205
6,823
5,214
988
378
78
24
0
2
18,712
2,114
2001
5,148
6,616
5,056
1,121
429
97
29
0
2
18,498
2,099
2002
5,091
6,415
4,903
1,243
475
118
36
0
3
18,284
2,086
2003
5,035
6,221
4,755
1,356
518
142
43
0
3
18,072
2,073
2004
4,981
6,034
4,612
1,461
558
168
50
0
4
17,869
2,061
2005
4,930
5,857
4,476
1,559
596
197
59
0
4
17,678
2,049
2006
4,883
5,688
4,348
1,650
631
226
68
0
4
17,499
2,039
2007
4,840
5,528
4,224
1,735
663
258
77
1
5
17,330
2,033
2008
4,799
5,376
4,108
1,815
694
291
87
1
6
17,176
2,026
2009
4,762
5,231
3,998
1,889
722
325
97
1
6
17,031
2,022
2010
4,728
5,094
3,893
1,959
748
362
108
1
7
16,900
2,018
2011
4,699
4,964
3,794
2,025
774
399
120
1
8
16,783
2,016
2012
4,672
4,842
3,701
2,086
797
437
131
1
9
16,675
2,018
2013
4,650
4,727
3,612
2,145
820
477
143
1
9
16,585
2,018
2014
4,631
4,620
3,531
2,200
840
518
155
1
10
16,506
2,022
2015
4,617
4,519
3,454
2,253
861
559
168
1
11
16,443
2,026
2016
4,606
4,426
3,382
2,304
881
603
181
1
12
16,395
2,034
2017
4,595
4,333
3,312
2,351
899
647
194
1
12
16,343
2,040
2018
4,582
4,242
3,242
2,394
915
690
207
1
13
16,287
2,048
2019
4,569
4,152
3,173
2,432
930
736
221
1
14
16,227
2,054
2020
4,555
4,063
3,105
2,467
943
780
234
1
15
16,163
2,059
2021
4,538
3,975
3,038
2,498
954
826
248
1
16
16,093
2,065
2022
4,520
3,888
2,971
2,525
964
870
261
2
17
16,018
2,069
2023
4,501
3,801
2,905
2,548
974
914
275
2
18
15,936
2,074
2024
4,479
3,715
2,839
2,567
981
958
287
2
18
15,847
2,076
2025
4,455
3,629
2,773
2,582
987
1,002
301
2
19
15,749
2,079
2026
4,428
3,543
2,708
2,594
991
1,046
313
2
20
15,644
2,079
2027
4,399
3,457
2,642
2,601
994
1,086
326
2
21
15,528
2,080
2028
4,367
3,372
2,577
2,604
995
1,128
339
2
21
15,405
2,076
2029
4,332
3,286
2,511
2,604
995
1,168
350
2
22
15,269
2,073
2030
4,293
3,200
2,445
2,598
993
1,205
361
2
23
15,119
2,070
2031
4,251
3,113
2,379
2,589
989
1,240
372
2
24
14,959
2,062
2032
4,204
3,026
2,312
2,575
984
1,275
382
2
24
14,785
2,052
2033
4,153
2,937
2,245
2,556
977
1,306
391
2
25
14,592
2,042
2034
4,096
2,849
2,177
2,533
968
1,335
401
2
25
14,386
2,027
2035
4,036
2,758
2,107
2,505
957
1,361
408
2
26
14,161
2,010
2036
3,970
2,667
2,038
2,472
945
1,384
415
2
26
13,919
1,989
2037
3,898
2,575
1,967
2,435
931
1,402
420
3
26
13,656
1,967
2038
3,821
2,481
1,896
2,392
914
1,417
425
3
27
13,375
1,940
2039
3,736
2,387
1,824
2,344
896
1,427
428
3
27
13,072
1,909
2040
3,646
2,290
1,750
2,291
875
1,434
430
3
27
12,746
1,875
2041
3,549
2,193
1,676
2,233
854
1,435
430
3
27
12,398
1,837
2042
3,446
2,094
1,601
2,169
829
1,431
429
3
27
12,029
1,791
2043
3,334
1,994
1,524
2,100
803
1,422
426
3
27
11,631
1,745
2044
3,216
1,893
1,447
2,026
775
1,406
422
3
26
11,212
1,693
2045
3,092
1,790
1,369
1,948
744
1,385
415
2
26
10,771
1,634
2046
2,959
1,687
1,289
1,863
712
1,358
407
2
25
10,301
1,575
2047
2,821
1,583
1,210
1,774
678
1,325
396
2
24
9,813
1,508
2048
2,677
1,478
1,130
1,682
643
1,285
385
2
24
9,305
1,434
2049
2,526
1,374
1,050
1,585
605
1,238
370
2
23
8,773
1,362
2050
2,369
1,269
970
1,485
568
1,185
355
2
22
8,226
1,285
2051
2,209
1,166
891
1,383
528
1,129
338
2
20
7,666
1,203
2052
2,047
1,064
813
1,278
489
1,066
319
2
19
7,097
1,119
2053
1,883
964
737
1,173
448
999
299
2
18
6,524
1,032
2054
1,717
867
663
1,068
408
928
278
2
17
5,946
946
2055
1,552
772
590
964
368
854
255
2
15
5,373
862
2056
1,392
682
522
862
329
779
233
1
14
4,814
774
2057
1,235
597
457
763
291
703
210
1
12
4,269
691
2058
1,085
517
396
668
256
628
188
1
11
3,751
608
2059
943
444
338
579
221
554
165
1
10
3,255
532
2060
810
376
287
496
190
485
144
1
8
2,797
457
2061
687
314
240
419
160
417
124
1
7
2,369
391
2062
576
259
198
350
133
354
106
1
6
1,984
327
2063
473
210
161
286
109
296
88
1
5
1,628
271
2064
382
167
128
230
88
243
72
0
4
1,315
219
2065
304
131
101
183
70
195
58
0
3
1,045
174
2066
237
102
77
142
55
154
46
0
3
815
137
2067
182
77
58
109
41
120
36
0
2
626
105
2068
137
57
43
81
31
92
27
0
1
470
80
2069
101
42
32
60
23
69
20
0
1
347
58
2070
72
30
23
43
16
50
14
0
1
247
42
2071
49
20
15
29
11
34
10
0
0
168
30
2072
31
12
9
19
8
22
7
0
0
108
19
2073
19
7
6
11
4
13
4
0
0
64
9
2074
8
3
3
5
2
6
2
0
0
29
3
2075
0
0
0
0
0
0
0
0
0
0
0
Total
234,001
178,830
123,751
47,289
55,768
16,714
98
1,039
916,265
119,992
Top of page

All life years and QALYs gained

YearAll Life Years GainedAll QALYs Gained
1991
45
658
1992
59
886
1993
84
1,164
1994
122
1,507
1995
184
1,945
1996
260
2,497
1997
356
3,202
1998
479
4,107
1999
636
5,269
2000
821
6,742
2001
1,008
7,196
2002
1,253
7,740
2003
1,558
8,313
2004
1,924
8,876
2005
2,357
9,411
2006
2,854
9,918
2007
3,406
10,409
2008
4,002
10,893
2009
4,633
11,373
2010
5,289
11,852
2011
5,957
12,328
2012
6,640
12,809
2013
7,327
13,292
2014
8,023
13,785
2015
8,734
14,300
2016
9,472
14,847
2017
10,167
15,358
2018
10,820
15,837
2019
11,429
16,277
2020
11,994
16,682
2021
12,515
17,051
2022
12,994
17,385
2023
13,432
17,686
2024
13,828
17,950
2025
14,183
18,180
2026
14,497
18,373
2027
14,771
18,531
2028
14,999
18,648
2029
15,187
18,729
2030
15,336
18,772
2031
15,438
18,774
2032
15,500
18,736
2033
15,520
18,660
2034
15,494
18,539
2035
15,425
18,376
2036
15,309
18,166
2037
15,146
17,911
2038
14,936
17,608
2039
14,681
17,260
2040
14,378
16,862
2041
14,024
16,414
2042
13,622
15,915
2043
13,174
15,371
2044
12,679
14,777
2045
12,136
14,133
2046
11,553
13,449
2047
10,931
12,723
2048
10,271
11,958
2049
9,583
11,163
2050
8,866
10,339
2051
8,134
9,498
2052
7,392
8,648
2053
6,647
7,794
2054
5,910
6,952
2055
5,196
6,133
2056
4,505
5,341
2057
3,853
4,592
2058
3,243
3,889
2059
2,691
3,250
2060
2,190
2,669
2061
1,758
2,162
2062
1,386
1,724
2063
1,074
1,351
2064
820
1,043
2065
612
789
2066
439
577
2067
298
404
2068
183
263
2069
88
145
2070
2
42
2071
2
30
2072
1
19
2073
-1
9
2074
-1
3
2075
0
0
Total
588,726
835,237

HIV, HCV and HIV+HCV projections

HIVHCVHIV+HCV
NPV All Years @5%
138,072
32,207
170,279
NPV All Years @3%
248,364
50,041
298,406
NPV All Years @0%
715,245
119,992
835,237
Top of page